-
Coelenterazine: From ROS Signal to Translational Insight
2026-09-16
Coelenterazine can do more than generate a bright luminescent readout: when its chemistry, reporter biology, and controls are aligned, it can help translational researchers connect reactive oxygen species with disease mechanism. This article develops an assay strategy informed by brain–kidney AVP research and cancer-associated ROS imaging.
-
GSK126: Assay Logic for EZH2-Driven Resistance
2026-09-16
GSK126 is a selective EZH2 inhibitor for dissecting how epigenetic state, ETV5 activity, and PRC2 dependence shape cancer-cell responses. This guide translates a recent pan-cancer study into practical assay decisions for cancer epigenetics research and oncology drug development.
-
Trichostatin A: Context-Resolved HDAC Biology
2026-09-15
Explore how Trichostatin A (TSA) links histone acetylation to cancer phenotypes, dendritic-cell metabolism, and assay design. This evidence-driven guide emphasizes context-resolved interpretation rather than endpoint-only HDAC inhibition.
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-09-15
The reference study identifies ziprasidone as a noncompetitive GOT1 inhibitor that disrupts glutamine-dependent redox metabolism in pancreatic ductal adenocarcinoma. Its combination of biochemical, cellular, metabolomic, genetic, and xenograft evidence supports GOT1 as a therapeutic vulnerability while also defining important limits for translation.
-
EdU Cell Proliferation Kit for RA S-Phase Studies
2026-09-14
Translate ARL4C-linked synoviocyte biology into direct DNA-synthesis data with a non-radioactive, TMB-based workflow. This 5-ethynyl-2'-deoxyuridine proliferation assay supports rheumatoid arthritis research, genotoxicity testing, and pharmacodynamic drug evaluation while preserving practical plate-reader throughput.
-
Phenacetin in hiPSC Intestinal PK Workflows
2026-09-14
Phenacetin provides a practical test article for connecting intestinal absorption, epithelial metabolism, and transporter activity in human pluripotent stem cell-derived organoids. This workflow combines controlled solvent preparation, 3D organoid expansion, 2D epithelial assays, and troubleshooting guidance for more reproducible pharmacokinetic studies.
-
BRD4770 and the Translational Logic of G9a
2026-09-13
BRD4770 offers translational researchers a focused way to interrogate G9a-dependent H3K9 methylation, senescence, and tumor-cell growth. This article connects product-level evidence from the pancreatic cancer cell line PANC-1 with a breast cancer study linking the c-MYC/G9a/FTH1 axis to BRD4-RAC1 co-targeting. The emphasis is not on treating a single phenotype as proof of mechanism, but on building a biomarker-led workflow that separates epigenetic engagement, senescence, and cell death.
-
SFRP1, Wnt/β-Catenin, and Oral Fibrosis
2026-09-12
The reference study identifies reduced SFRP1 as a feature of arecoline-induced oral submucous fibrosis and links its loss to neutrophil infiltration, collagen accumulation, and activation of Wnt/β-catenin signaling. Its combination of tissue correlation, SFRP1 overexpression, and pathway-activation rescue experiments provides a useful framework for testing how inflammatory and fibrotic mechanisms interact in oral disease.
-
7-dehydro Cholesterol in Sterol Research
2026-09-11
7-dehydro Cholesterol enables controlled studies of sterol flux, UVB-driven vitamin D3 formation, and oxidation-sensitive lipid signaling. Its strongest value comes from pairing exogenous metabolite exposure with DHCR7 genetics, sterol profiling, and functional immune or tissue readouts.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-11
Use dual Cy5 tracking and EGFP expression to separate cellular delivery from productive translation in mammalian cells. This practical workflow shows how a 5-methoxyuridine modified mRNA can benchmark emerging lipid and polymer-based delivery systems while exposing common handling and readout failures.
-
LG 101506 for RXR Signaling Research
2026-09-10
LG 101506 is a research-grade RXR modulator for connecting receptor activity with transcriptional, metabolic, and immune-cell phenotypes. This practical guide presents dose-finding, reporter, gene-expression, and TNBC co-culture workflows while clearly separating established evidence from testable hypotheses.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-10
Use one transcript to distinguish mRNA delivery from productive protein expression: Cy5 reveals where the cargo goes, while Firefly Luciferase reports whether it is translated. This dual-readout workflow supports transfection optimization, intracellular trafficking studies, and in vivo bioluminescence imaging with clearer troubleshooting than either modality alone.
-
From Fluorescence to Function in mRNA Delivery
2026-09-09
A thought-leadership guide to using dual-readout mRNA controls to connect particle delivery, intracellular localization, and protein expression. The article explains how ARCA capping and 5-methoxyuridine modification strengthen translational assay design while positioning fluorescence-based validation as a bridge to more predictive mRNA delivery systems.
-
mRNA Lipoplexes as Intravenous Tumour Vaccines
2026-09-09
Hattori and colleagues optimized PEGylation of cationic mRNA lipoplexes to reduce lung accumulation while preserving systemic tumour-vaccine activity. The resulting formulation generated strong anti-OVA antibody and cytotoxic responses and suppressed E.G7-OVA tumour growth in mice, highlighting how carrier composition can balance biodistribution and immunogenicity.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-08
Build a dual-readout assay that separates mRNA delivery from protein translation in mammalian cells. This workflow combines Cy5 tracking, EGFP expression, and carrier comparisons to improve mRNA delivery system research, including macrophage-focused studies.